» Articles » PMID: 15286970

Detection of Circulating Oesophageal Squamous Cancer Cells in Peripheral Blood and Its Impact on Prognosis

Overview
Journal Br J Surg
Specialty General Surgery
Date 2004 Aug 3
PMID 15286970
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Many studies have attempted to detect cancer cells using the reverse transcription-polymerase chain reaction (RT-PCR) for specific mRNAs. None has examined the correlation between the presence of circulating oesophageal cancer cells in peripheral blood and long-term outcome.

Methods: Blood samples were obtained on admission, and before, during and after operation from 70 patients with squamous oesophageal cancer who had complete clinicopathological records and who underwent curative oesophagectomy between June 1997 and June 2000. RT-PCR for mRNA encoding squamous cell carcinoma antigen (SCCA mRNA) was used to detect oesophageal cancer cells in peripheral blood.

Results: Twenty-three patients (33 per cent) were positive for SCCA mRNA on admission and 17 of these patients developed recurrent disease. SCCA mRNA on admission correlated with the depth of tumour invasion (P < 0.001) and with venous invasion (P < 0.001). Eleven of 24 patients with a positive intraoperative result were positive for SCCA mRNA only during operation, of whom seven also developed recurrence.

Conclusion: RT-PCR for SCCA mRNA can detect oesophageal cancer cells in peripheral blood. The presence of such cells in blood samples obtained on admission or during operation is a useful predictor of outcome in patients with oesophageal squamous cell carcinoma.

Citing Articles

Prognostic Value of Combination of Lymphocyte-to-Monocyte-Ratio and CYFRA 21-1 in Esophageal Squamous Cell Carcinoma.

Yang Y, Liu Z, Jiang C, Pan J, Yu B, Zhu K World J Surg. 2023; 47(12):3240-3249.

PMID: 37792039 DOI: 10.1007/s00268-023-07190-3.


Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.

Yu E, Allan A, Sanatani M, Lewis D, Warner A, Dar A BMC Cancer. 2022; 22(1):746.

PMID: 35804307 PMC: 9264673. DOI: 10.1186/s12885-022-09846-0.


Hybrid microfluidic sorting of rare cells based on high throughput inertial focusing and high accuracy acoustic manipulation.

Zhou Y, Ma Z, Ai Y RSC Adv. 2022; 9(53):31186-31195.

PMID: 35529382 PMC: 9072550. DOI: 10.1039/c9ra01792e.


Detection of Circulating and Disseminated Tumor Cells and Their Prognostic Value under the Influence of Neoadjuvant Therapy in Esophageal Cancer Patients.

Richter F, Roder C, Moller T, Egberts J, Becker T, Sebens S Cancers (Basel). 2022; 14(5).

PMID: 35267585 PMC: 8909540. DOI: 10.3390/cancers14051279.


Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC-chip" for primary lung cancer.

Kanayama M, Kuwata T, Mori M, Nemoto Y, Nishizawa N, Oyama R Cancer Sci. 2021; 113(3):1028-1037.

PMID: 34964211 PMC: 8898730. DOI: 10.1111/cas.15255.